5020 related articles for article (PubMed ID: 6188530)
21. Immunodiagnosis of human melanoma: characterization of human melanoma antigens and their detection in sera of melanoma patients by radioimmunoassay.
Ishii Y; Mavligit GM
Oncology; 1982; 39(1):23-8. PubMed ID: 6173826
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
[TBL] [Abstract][Full Text] [Related]
23. Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects.
Luo W; Ko E; Hsu JC; Wang X; Ferrone S
J Immunol; 2006 May; 176(10):6046-54. PubMed ID: 16670313
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
Kageshita T; Nakamura T; Yamada M; Kuriya N; Arao T; Ferrone S
Cancer Res; 1991 Mar; 51(6):1726-32. PubMed ID: 1671829
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneous expression of melanoma-associated antigens and HLA antigens by primary and multiple metastatic lesions removed from patients with melanoma.
Natali P; Bigotti A; Cavaliere R; Liao SK; Taniguchi M; Matsui M; Ferrone S
Cancer Res; 1985 Jun; 45(6):2883-9. PubMed ID: 3157450
[TBL] [Abstract][Full Text] [Related]
26. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
27. Equilibrium binding characteristics of monoclonal antibodies recognizing melanoma cell surface antigens.
Shockley TR; Mandeville JT; Tompkins RG; Yarmush ML
Hybridoma; 1990 Dec; 9(6):527-44. PubMed ID: 2076895
[TBL] [Abstract][Full Text] [Related]
28. Differential immunogenicity of two peptides isolated by high molecular weight-melanoma-associated antigen-specific monoclonal antibodies with different affinities.
Luo W; Hsu JC; Tsao CY; Ko E; Wang X; Ferrone S
J Immunol; 2005 Jun; 174(11):7104-10. PubMed ID: 15905554
[TBL] [Abstract][Full Text] [Related]
29. Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma.
Tordsson JM; Ohlsson LG; Abrahmsén LB; Karlström PJ; Lando PA; Brodin TN
Cancer Immunol Immunother; 2000 Mar; 48(12):691-702. PubMed ID: 10752477
[TBL] [Abstract][Full Text] [Related]
30. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.
Wilson BS; Imai K; Natali PG; Ferrone S
Int J Cancer; 1981 Sep; 28(3):293-300. PubMed ID: 7033148
[TBL] [Abstract][Full Text] [Related]
31. Characterization of antigenic components of immune complexes isolated from a melanoma patient.
Cheng WC; Gupta RK; Morton DL
Immunol Invest; 1985 Aug; 14(4):367-78. PubMed ID: 4065936
[TBL] [Abstract][Full Text] [Related]
32. Immunochemical analysis of the modulation of human melanoma-associated antigens by DNA recombinant immune interferon.
Giacomini P; Imberti L; Aguzzi A; Fisher PB; Trinchieri G; Ferrone S
J Immunol; 1985 Oct; 135(4):2887-94. PubMed ID: 3928760
[TBL] [Abstract][Full Text] [Related]
33. Identification and isolation of melanoma-associated antigens with monoclonal antibodies.
Ross AH; Mitchell KF; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(4):413-21. PubMed ID: 6765324
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody defined-human melanoma-associated antigens: molecular and phylogenetic studies in normal serum.
Morgan AC; McIntyre RF
Mol Immunol; 1983 Dec; 20(12):1293-9. PubMed ID: 6656776
[TBL] [Abstract][Full Text] [Related]
35. Specificity of mimotope-induced anti-high molecular weight-melanoma associated antigen (HMW-MAA) antibodies does not ensure biological activity.
Latzka J; Gaier S; Hofstetter G; Balazs N; Smole U; Ferrone S; Scheiner O; Breiteneder H; Pehamberger H; Wagner S
PLoS One; 2011 May; 6(5):e19383. PubMed ID: 21573118
[TBL] [Abstract][Full Text] [Related]
36. Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies.
Drake AS; Brady MT; Wang XH; Sait SJ; Earp JC; Ghoshal Gupta S; Ferrone S; Wang ES; Wetzler M
Cancer Immunol Immunother; 2009 Mar; 58(3):415-27. PubMed ID: 18677475
[TBL] [Abstract][Full Text] [Related]
37. Biosynthesis, glycosylation and intracellular processing of the neuroglandular antigen, a human melanoma-associated antigen.
Dixon WT; Demetrick DJ; Ohyama K; Sikora LK; Jerry LM
Cancer Res; 1990 Aug; 50(15):4557-65. PubMed ID: 2369731
[TBL] [Abstract][Full Text] [Related]
38. High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells.
Riemer AB; Hantusch B; Sponer B; Kraml G; Hafner C; Zielinski CC; Scheiner O; Pehamberger H; Jensen-Jarolim E
Cancer Immunol Immunother; 2005 Jul; 54(7):677-84. PubMed ID: 15565329
[TBL] [Abstract][Full Text] [Related]
39. Double determinant immunoassay to measure a human high-molecular-weight melanoma-associated antigen.
Giacomini P; Ng AK; Kantor RR; Natali PG; Ferrone S
Cancer Res; 1983 Aug; 43(8):3586-90. PubMed ID: 6344987
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
